Search
for

    Sort by

    Research 181–210 of 1000+

    1. Safety, tolerability, and pharmacokinetics of CG2001 in Chinese adult male subjects with androgenetic alopecia: a randomized, double-blind, placebo-controlled, single- and multi-doses, phase 1 clinical study 2026
    2. Introduction and Summary of Findings NBER Chapters · 1972
    3. A synbiotic preparation (SIM01) for post-acute COVID-19 syndrome in Hong Kong (RECOVERY): a randomised, double-blind, placebo-controlled trial 2023 · 6 citations
    4. 5-Alpha-Reductase Inhibitors Reduce Remission Time of COVID-19: Results From a Randomized Double Blind Placebo Controlled Interventional Trial in 130 SARS-CoV-2 Positive Men medRxiv (Cold Spring Harbor Laboratory) · 2020 · 5 citations
    5. Efficacy, Safety, and Tolerability of Upadacitinib in Adults and Adolescents With Severe Alopecia Areata: Results From the Randomized, Placebo-Controlled, Double-Blind Phase 3 Program (UP-AA) SKIN The Journal of Cutaneous Medicine · 2025
    6. Platelet-Rich Plasma for Urologic Conditions: An Early Call for Composition Reporting The Journal of Urology · 2023
    7. Evaluation of Patellar Tendon Structural Changes following Biological Treatments: Secondary Analysis of Double-Blinded Clinical Trial of Bone Marrow Mesenchymal Stromal Cells and Leukocyte-Poor Platelet-Rich Plasma Biomedicines · 2024 · 2 citations
    8. Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial Journal of the American Academy of Dermatology · 2025 · 2 citations
    9. 51840 Efficacy of the Oral JAK1/JAK2 Inhibitor Deuruxolitinib in Adult Patients with Moderate to Severe Alopecia Areata: Pooled Results from the Multinational Double-Blind, Placebo-Controlled THRIVE-AA1 and THRIVE-AA2 Phase 3 Trials Journal of the American Academy of Dermatology · 2024 · 2 citations
    10. Efficacy and tolerability of HDMHG0401-10 in Patients with Androgenetic Alopecia: A Randomized Double-blind Placebo-controlled Trial 임상약리학회지 · 2005 · 1 citations
    11. Management of Androgenetic Alopecia in Postmenopausal Women Actas Dermo-Sifiliográficas · 2008 · 1 citations
    12. Efficacy of Botulinum Toxin in Male Androgenetic Alopecia: a Triple-Blind, Randomized Clinical Trial Journal of the American Academy of Dermatology · 2024
    13. Silymarin in combination with hair follicle transplantation as a potential treatment for refractory vitiligo: A double‐blind randomized controlled trial Journal of Cosmetic Dermatology · 2024 · 2 citations
    14. Proxalutamide Significantly Accelerates Viral Clearance and Reduces Time to Clinical Remission in Patients with Mild to Moderate COVID-19: Results from a Randomized, Double-Blinded, Placebo-Controlled Trial Cureus · 2021 · 41 citations
    15. Maintenance, withdrawal, and re-treatment with ritlecitinib and brepocitinib in patients with alopecia areata in a single-blind extension of a phase 2a randomized clinical trial Journal of the American Academy of Dermatology · 2021 · 20 citations
    16. Effect of Pumpkin Seed Oil on Hair Growth in Men with Androgenetic Alopecia: A Randomized, Double-Blind, Placebo-Controlled Trial Evidence-based Complementary and Alternative Medicine · 2014 · 36 citations
    17. A Prospective, Randomized, Double-Blind, Placebo-Controlled Clinical Study of Efficacy and Safety of Ashwagandha Root Extract Capsule on Skin and Hair Health in Healthy Adults. PubMed · 2026
    18. Comparative efficacy of topical hair growth serums on hair density and shedding: a double-blinded and randomized clinical trial International Journal of Research in Dermatology · 2026
    19. Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial – Biochemical) Cureus · 2021 · 41 citations
    20. Multi-Herbal Extracellular Vesicle and Growth Factor Serum for Eyelash Care: A Pilot Randomized, Double Blind, Placebo-Controlled Clinical Study medRxiv · 2026
    21. 51252 Oral supplementation with L-Cystine, Serenoa repens, Pumpkin seed oil and Pygeum africanum in Chronic Telogen Effluvium and Androgenetic Alopecia: A double-blind, placebo-controlled, randomized clinical study Journal of the American Academy of Dermatology · 2024
    22. TH07-A New Novel Topical Treatment for Androgenic Alopecia American Journal of Biomedical Science & Research · 2024
    23. The selective androgen receptor modulator GTx‐024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double‐blind, placebo‐controlled phase II trial Journal of cachexia, sarcopenia and muscle · 2011 · 306 citations
    24. Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial The Lancet · 2023 · 227 citations
    25. Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double‐blind placebo‐controlled trial Journal of the European Academy of Dermatology and Venereology · 2006 · 114 citations
    26. Can the golden nutraceutical frankincense combat COVID‐19? Future postharvest and food · 2024
    27. Platelet-Rich Plasma: Applications in Dermatology 2015 · 22 citations
    28. The beneficial effects of Pumpkin (<i>Cucurbita pepo</i>L.) seed oil for health condition of men Food Reviews International · 2018 · 15 citations
    29. Efficacy and Safety of SER120 Nasal Spray in Patients with Nocturia: Pooled Analysis of 2 Randomized, Double-Blind, Placebo Controlled, Phase 3 Trials 2018 · 21 citations
    30. Comparison between melatonin versus melatonin and photobiomodulation versus photobiomodulation in the treatment of Alopecia X in German Spitz dogs: Clinical, randomized, double-blind, parallel, non-inferiority protocol PloS one · 2024